# STC OpCo LLC – FDA Inspection, Aug 12, 2022

Source: https://www.keypedia.com/records/fda_inspections/stc-opco-llc/ea13172b-7c07-4f07-939e-489411322293
Source feed: FDA_Inspections

> FDA inspection 1178861 of STC OpCo LLC, August 12, 2022. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1178861
- Company Name: STC OpCo LLC
- Inspection Date: 2022-08-12
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1244791 - 2024-07-10](https://www.keypedia.com/records/fda_inspections/stc-opco-llc/58371dc2-ca77-4276-9b9f-b7f7207e573b)
- FDA Inspection 1037198 - 2017-12-14
- FDA Inspection 961395 - 2016-03-04
- FDA Inspection 872672 - 2014-04-02
- FDA Inspection 803141 - 2012-10-01

Company: https://www.keypedia.com/companies/stc-opco-llc/27523328-a1ef-44f7-a07a-25991397dd5f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d